Status:
COMPLETED
Comparison of Train of Four, Tetanus 50 and 100 Hz Recovery After Rocuronium Block Reversed by Neostigmine
Lead Sponsor:
Poitiers University Hospital
Conditions:
Postoperative Residual Curarization
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Despite neuromuscular transmission monitoring and pharmacological reversal allowing a train of four ratio recovery higher than 0.9, patients receiving neuromuscular blocking agent during general anest...
Eligibility Criteria
Inclusion
- ASA clinical status 1 to 3 informed consent obtained before anesthesia induction
Exclusion
- ASA clinical status 4 emergency surgery scheduled surgery in prone position hepatic or renal disease BMI higher than 35 allergy to rocuronium or neostigmine
Key Trial Info
Start Date :
June 22 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 18 2022
Estimated Enrollment :
21 Patients enrolled
Trial Details
Trial ID
NCT05224648
Start Date
June 22 2022
End Date
November 18 2022
Last Update
January 13 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Poitiers
Poitiers, France, 86021